EUVIMEDEUVIMED entdecken
Open Access

Hydroxysafflor yellow A induced ferroptosis of Osteosarcoma cancer cells by HIF-1α/HK2 and SLC7A11 pathway

Yiwen Zhu, Liu Yang, Ying Yu, Ying Xiong, Ping Xiao, Xiao Fu, Xin Luo

Oncology Research · 2024

DOI: 10.32604/or.2023.042604 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2024. Verfasst von Yiwen Zhu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, 330006, China. Hauptthemen laut MEDLINE: Bone Neoplasms, Cell Proliferation, Chalcone, Ferroptosis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteosarcoma is a very serious primary bone cancer with a high death rate and a dismal prognosis. Since there is no permanent therapy for this condition, it is necessary to develop a cure. Therefore, this investigation was carried out to assess the impacts and biological functions of hydroxysafflor yellow A (HYSA) in osteosarcoma cell lines (MG63). In this investigational study, MG63 cells were utilized. Microarray experiments, quantitative polymerase chain reaction (qPCR), immunofluorescent staining, extracellular acidification rate (ECAR), oxygen consumption rate (OCR), glucose consumption, lactate production, and ATP levels, proliferation assay, 5-Ethynyl-2'-deoxyuridine (EDU) staining, and Western blot were performed. In MG63 cells, HYSA lowered cell proliferation and metastasis rates, suppressed EDU cell number, and enhanced caspase-3/9 activity levels. HYSA reduced the Warburg effect and induced ferroptosis (FPT) in MG63 cells. Inhibiting ferroptosis diminished HYSA's anti-cancer activities in MG63 cells. The stimulation of the HIF-1α/SLC7A11 pathway decreased HYSA's anti-cancer activities in MG63 cells. HIF-1α is one target spot for HYSA in a model of osteosarcoma cancer (OC). HYSA altered HIF-1α's thermophoretic activity; following binding with HYSA, HIF-1α's melting point increased from ~55°C to ~60°C. HYSA significantly enhanced the thermal stability of exogenous WT HIF-1α while not affecting Mut HIF-1α, suggesting that ARG-311, GLY-312, GLN-347, and GLN-387 may be involved in the interaction between HIF-1α and HYSA. Conclusively, our study revealed that HYSA induced FPT and reduced the Warburg effect of OC through mitochondrial damage by HIF-1α/HK2/SLC7A11 pathway. HYSA is a possible therapeutic option for OC or other cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone NeoplasmsCell ProliferationChalconeFerroptosisOsteosarcomaQuinonesHumansAmino Acid Transport System y+Cell Line, TumorHypoxia-Inducible Factor 1, alpha SubunitSignal TransductionHexokinase

Stichwörter der Autor:innen

FPTHIF-1αHydroxysafflor yellow AOsteosarcoma

Substanzen

Amino Acid Transport System y+ChalconeHIF1A protein, humanhydroxysafflor yellow AHypoxia-Inducible Factor 1, alpha SubunitQuinonesSLC7A11 protein, humanHK2 protein, humanHexokinase

Autor:innen und Institutionen

  • Department of Rehabilitation Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, 330006, China.
  • Department of General Practice, The Second Affiliated Hospital of Nanchang University, Nanchang, 330006, China.

Zitieren

APA

Zhu, Y., Yang, L., Yu, Y., Xiong, Y., Xiao, P., Fu, X., & Luo, X. (2024). Hydroxysafflor yellow A induced ferroptosis of Osteosarcoma cancer cells by HIF-1α/HK2 and SLC7A11 pathway. Oncology Research. https://doi.org/10.32604/or.2023.042604

Vancouver

Zhu Y, Yang L, Yu Y, Xiong Y, Xiao P, Fu X, et al. Hydroxysafflor yellow A induced ferroptosis of Osteosarcoma cancer cells by HIF-1α/HK2 and SLC7A11 pathway. Oncology Research. 2024. doi:10.32604/or.2023.042604

BibTeX
@article{Zhu2024,
  author = {Zhu, Yiwen and Yang, Liu and Yu, Ying and Xiong, Ying and Xiao, Ping and Fu, Xiao and Luo, Xin},
  title = {Hydroxysafflor yellow A induced ferroptosis of Osteosarcoma cancer cells by HIF-1α/HK2 and SLC7A11 pathway},
  journal = {Oncology Research},
  year = {2024},
  doi = {10.32604/or.2023.042604}
}
Kostenlos starten →